Inactivated Vaccines Global Market Report 2024

Inactivated Vaccines Global Market Report 2024 – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

Inactivated Vaccines Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Inactivated Vaccines Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Inactivated Vaccines Market Definition And Segments

Inactivated vaccines, also known as killed vaccines, are a type of vaccine that contains viruses or bacteria that have been killed or inactivated using heat, chemicals, or radiation. These vaccines are designed to stimulate an immune response without causing disease in the vaccinated individual.

The main types of inactivated vaccines are viral and bacterial vaccines. A viral vaccine is a biological preparation containing weakened or inactivated virus components to stimulate the immune system and provide immunity against the targeted viral infection. These are inactivated by solvent detergent, radiation, pH concentration, heat inactivation and others and are distributed by hospital pharmacies, retail pharmacies and others.

The inactivated vaccines market covered in this report is segmented –

1) By Type: Viral Vaccine, Bacterial Vaccine

2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

The inactivated vaccines market size has grown steadily in recent years. It will grow from $5.95 billion in 2023 to $6.19 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to polio eradication efforts, influenza vaccination programs, emerging infectious diseases, regulatory approvals.

The inactivated vaccines market size is expected to see steady growth in the next few years. It will grow to $7.33 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine coverage, biomanufacturing advancements, health equity initiatives. Major trends in the forecast period include mrna vaccine platforms, combination vaccines, thermostable vaccines, digital vaccine passports.

Rising Prevalence Of Infectious Diseases Boost Inactivated Vaccines Market In Combating Diseases

The increasing prevalence of infectious diseases is expected to propel the growth of the inactivated vaccine market going forward. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread from person to person, resulting in a wide range of symptoms and health complications. Tuberculosis is one type of infectious disease. Inactivated vaccines use non-living pathogens to stimulate an immune response, effectively preventing diseases like polio, hepatitis A and influenza. For instance, in October 2022, according to the Global Tuberculosis Report published by the World Health Organization, a Switzerland-based global health agency, there will be a 4.5% increase in the global incidence of tuberculosis from the projected 10.1 million cases to 10.6 million cases in 2021. The majority of tuberculosis cases were reported in the Southeast Asia region, accounting for 45% of the total, followed by Africa with 23% of the cases. Therefore, the increasing prevalence of infectious diseases is driving the growth of the inactivated vaccine market.

Increasing Immunization Initiatives To Drive The Growth Of Inactivated Vaccines Market

The increasing immunization initiatives are expected to propel the growth of the inactivated vaccines market going forward. Immunization initiatives refer to organized efforts or campaigns aimed at vaccinating individuals or communities to protect them from specific infectious diseases. Growing immunization initiatives are a significant factor in the inactivation vaccines. Increased vaccination efforts lead to higher demand for inactivated vaccines, stimulating market growth and fostering research and development investments. For instance, in July 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, each year, vaccines prevent the loss of 4-5 million lives globally by protecting against infectious diseases like hepatitis, diphtheria, tetanus, pertussis (whooping cough), measles, and polio. Moreover, in 2022, around 84% of infants globally received three doses of the polio vaccine. Similarly, it's estimated that 84% of infants in countries using oral polio vaccine (OPV) received their first dose of inactivated polio vaccine (IPV) during the same year. Therefore, the increasing immunization initiatives are driving the growth of the inactivated vaccines market.

Major players in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .

Impact Of High Fixed Costs On The Inactivated Vaccines Market

The high fixed costs constrain the inactivated vaccines market's growth during the forecast period. The high fixed costs are a major challenge for inactivated vaccines. These costs can lead to reduced innovation, limited access to vaccines, increased prices, reduced demand for vaccines, increased reliance on government subsidies, and reduced profitability for vaccine manufacturers. For instance, in July 2022, according to the National Library of Medicine, a biomedical library, the cost of establishing facilities for the production of inactivated vaccines can vary significantly, ranging from $50 million to $500 million per antigen, with the complexity of the facility being the determining factor. Therefore, the high fixed costs are hindering the growth of the inactivated vaccines market.

Innovative Advancements In Inactivated Vaccines By Leading Companies For Disease Prevention

Major companies operating in the inactivated vaccines market are introducing innovative and advanced inactivated vaccines to sustain their position in the market. An inactivated vaccine contains inactivated virus particles, bacteria, or other pathogens that have been developed in culture and subsequently killed to destroy disease-producing ability. For instance, in January 2022, GSK PLC, a UK-based pharmaceutical and biotechnology company, released a new inactivated vaccination to aid with shingles protection named Shingrix to prevent shingles (Herpes zoster). Shingrix is a non-live, recombinant subunit adjuvanted vaccination administered intramuscularly in two doses. The vaccine's initial indication was for individuals 50 years and older. It has lately been expanded to cover persons 18 and older at a higher risk of developing shingles due to immunodeficiency or immunosuppression caused by a known illness or treatment.

Collaboration Between Albumedix Ltd. And Valneva To Boost Inactivated COVID-19 Vaccine Production Capacity

In April 2022, Albumedix Ltd., a UK-based biotechnology company, collaborated with Valneva SE. The development of the collaboration between Albumedix Ltd. and Valneva is anticipated to contribute to an increase in the inactivated COVID-19 vaccine's production capacity to fulfill the rising demand for COVID-19 vaccines. Valneva SE is a France-based biotech company specializing in discovering, producing and marketing inactivated vaccines for infectious illnesses.

North America was the largest region in the inactivated vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the inactivated vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The inactivated vaccines market consists of sales of whole-cell inactivated vaccines, subunit or protein subunit vaccines, conjugate vaccines and toxoid vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The inactivated vaccines market research report is one of a series of new reports from The Business Research Company that provides inactivated vaccines market statistics, including inactivated vaccines industry global market size, regional shares, competitors with an inactivated vaccines market share, detailed inactivated vaccines market segments, market trends and opportunities and any further data you may need to thrive in the inactivated vaccines industry. This inactivated vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Inactivated Vaccines Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $6.19 billion
Revenue Forecast In 2033 $7.33 billion
Growth Rate CAGR of 4.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson Services Inc.; Sinopharm Group Co. Ltd.; Merck & Co. Inc.; Sanofi S.A.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Astellas Pharma Inc.; CSL Limited; Daiichi Sankyo Company Limited; Mitsubishi Tanabe Pharma Corporation; Novavax Inc.; Zydus Lifesciences Ltd.; Sinovac Biotech Ltd.; Biological E Limited; Hualan Biological Engineering Inc.; CanSino Biologics Inc.; Shenzhen Kangtai Biological Products Co. Ltd.; Serum Institute of India Pvt. Ltd.; Beijing Tiatan Biological Products Co. Ltd.; Valneva SE; Bavarian Nordic A/S.; Beijing Minhai Biotechnology Co. Ltd.; Bharat Biotech International Limited; Panacea Biotec Ltd.; Sinergium Biotech SA; Bharat Immunologicals and Biologicals Corporation Limited; Haffkine Biopharmaceutical Corporation Limited; Incepta Vaccine Ltd.; Changchun BCHT Biotechnology Co. Ltd.;
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Inactivated Vaccines Market Characteristics

    3. Inactivated Vaccines Market Trends And Strategies

    4. Inactivated Vaccines Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Inactivated Vaccines Market Size and Growth

    5.1. Global Inactivated Vaccines Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Inactivated Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Inactivated Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Inactivated Vaccines Market Segmentation

    6.1. Global Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Viral Vaccine

    Bacterial Vaccine

    6.2. Global Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Solvent Detergent

    Radiation

    pH Concentration

    Heat Inactivation

    Other Methods Of Inactivation

    6.3. Global Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Other Distribution Channels

    7. Inactivated Vaccines Market Regional And Country Analysis

    7.1. Global Inactivated Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Inactivated Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Inactivated Vaccines Market  

    8.1. Asia-Pacific Inactivated Vaccines Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Inactivated Vaccines Market  

    9.1. China Inactivated Vaccines Market Overview  

    9.2. China Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Inactivated Vaccines Market  

    10.1. India Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Inactivated Vaccines Market  

    11.1. Japan Inactivated Vaccines Market Overview  

    11.2. Japan Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Inactivated Vaccines Market  

    12.1. Australia Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Inactivated Vaccines Market  

    13.1. Indonesia Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Inactivated Vaccines Market  

    14.1. South Korea Inactivated Vaccines Market Overview  

    14.2. South Korea Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Inactivated Vaccines Market  

    15.1. Western Europe Inactivated Vaccines Market Overview

    15.2. Western Europe Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Inactivated Vaccines Market  

    16.1. UK Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Inactivated Vaccines Market  

    17.1. Germany Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Inactivated Vaccines Market  

    18.5. France Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Inactivated Vaccines Market  

    19.9. Italy Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Inactivated Vaccines Market  

    20.13. Spain Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Inactivated Vaccines Market  

    21.1. Eastern Europe Inactivated Vaccines Market Overview

    21.2. Eastern Europe Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Inactivated Vaccines Market  

    22.1. Russia Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Inactivated Vaccines Market  

    23.1. North America Inactivated Vaccines Market Overview

    23.2. North America Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Inactivated Vaccines Market  

    24.1. USA Inactivated Vaccines Market Overview

    24.2. USA Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Inactivated Vaccines Market  

    25.1. Canada Inactivated Vaccines Market Overview

    25.2. Canada Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Inactivated Vaccines Market  

    26.1. South America Inactivated Vaccines Market Overview

    26.2. South America Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Inactivated Vaccines Market  

    27.1. Brazil Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Inactivated Vaccines Market  

    28.1. Middle East Inactivated Vaccines Market Overview

    28.2. Middle East Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Inactivated Vaccines Market  

    29.1. Africa Inactivated Vaccines Market Overview

    29.2. Africa Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Inactivated Vaccines Market Competitive Landscape And Company Profiles

    30.1. Inactivated Vaccines Market Competitive Landscape

    30.2. Inactivated Vaccines Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson Services Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Sinopharm Group Co. Ltd.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck & Co. Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Sanofi S.A.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Inactivated Vaccines Market Other Major And Innovative Companies

    31.1. GlaxoSmithKline plc

    31.2. Takeda Pharmaceutical Company Limited

    31.3. Astellas Pharma Inc.

    31.4. CSL Limited

    31.5. Daiichi Sankyo Company Limited

    31.6. Mitsubishi Tanabe Pharma Corporation

    31.7. Novavax Inc.

    31.8. Zydus Lifesciences Ltd.

    31.9. Sinovac Biotech Ltd.

    31.10. Biological E Limited

    31.11. Hualan Biological Engineering Inc.

    31.12. CanSino Biologics Inc.

    31.13. Shenzhen Kangtai Biological Products Co. Ltd.

    31.14. Serum Institute of India Pvt. Ltd.

    31.15. Beijing Tiatan Biological Products Co. Ltd.

    32. Global Inactivated Vaccines Market Competitive Benchmarking

    33. Global Inactivated Vaccines Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Inactivated Vaccines Market

    35. Inactivated Vaccines Market Future Outlook and Potential Analysis

    35.1 Inactivated Vaccines Market In 2028 - Countries Offering Most New Opportunities

    35.2 Inactivated Vaccines Market In 2028 - Segments Offering Most New Opportunities

    35.3 Inactivated Vaccines Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Inactivated Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Inactivated Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Johnson & Johnson Services Inc. Financial Performance
  • Table 76: Sinopharm Group Co. Ltd. Financial Performance
  • Table 77: Merck & Co. Inc. Financial Performance
  • Table 78: Sanofi S.A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Inactivated Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Inactivated Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Inactivated Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Inactivated Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Inactivated Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Johnson & Johnson Services Inc. Financial Performance
  • Figure 76: Sinopharm Group Co. Ltd. Financial Performance
  • Figure 77: Merck & Co. Inc. Financial Performance
  • Figure 78: Sanofi S.A. Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Cancer Vaccines Global Market Report 2024 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
DTP Vaccines Global Market Report 2024 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Companion Animal Veterinary Vaccines Global Market Report 2024 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pediatric Vaccine Global Market Report 2024 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, Cancer) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Vaccines Global Market Report 2024 – By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types), By Disease Type (Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Meningococcal Vaccines Global Market Report 2024 – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Children, Adolescents and Young Adults, Adults), By Distribution Channel ( (Pharmacies, Community Clinics, Public Health Agencies, Other Channels), By End user (Hospitals, Research, Academic Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Swine Vaccines Global Market Report 2024 – By Product( Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA (Deoxyribonucleic Acid) Vaccines, Recombinant Vaccines), By Disease( Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Other Diseases), By Distribution Channel( Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), By Application( Government Tender, Market Sales) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Typhoid Vi Polysaccharide Vaccine Global Market Report 2024 – By Type( Child, Adult ), By Route of Administration( Oral, Parenteral ), By Application( Government Institution, Private Sector, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the inactivated vaccines market?

Inactivated vaccines, also known as killed vaccines, are a type of vaccine that contains viruses or bacteria that have been killed or inactivated using heat, chemicals, or radiation. These vaccines are designed to stimulate an immune response without causing disease in the vaccinated individual. request a sample here

How will the inactivated vaccines market drivers and restraints affect the inactivated vaccines market dynamics? What forces will shape the inactivated vaccines industry going forward?

The inactivated vaccines market major growth driver - Rising Prevalence Of Infectious Diseases Boost Inactivated Vaccines Market In Combating Diseases. request a sample here

What is the forecast market size or the forecast market value of the inactivated vaccines market?

The inactivated vaccines market size has grown steadily in recent years. It will grow from $5.95 billion in 2023 to $6.19 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to polio eradication efforts, influenza vaccination programs, emerging infectious diseases, regulatory approvals. The inactivated vaccines market size is expected to see steady growth in the next few years. It will grow to $7.33 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine coverage, biomanufacturing advancements, health equity initiatives. Major trends in the forecast period include mrna vaccine platforms, combination vaccines, thermostable vaccines, digital vaccine passports. request a sample here

How is the inactivated vaccines market segmented?

The inactivated vaccines market is segmented
1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution ChannelsFor further insights on the inactivated vaccines market request a sample here

Which region has the largest share of the inactivated vaccines market? What are the other regions covered in the report?

North America was the largest region in the inactivated vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the inactivated vaccines market?

Major players in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., . request a sample here.

What are the key trends in the inactivated vaccines market?

Major trend in the inactivated vaccines market - Innovative Advancements In Inactivated Vaccines By Leading Companies For Disease Prevention. request a sample here.

What are the major opportunities in the inactivated vaccines market? What are the strategies for the inactivated vaccines market?

For detailed insights on the major opportunities and strategies in the inactivated vaccines market, request a sample here.

How does the inactivated vaccines market relate to the overall economy and other similar markets?

For detailed insights on inactivated vaccines market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the inactivated vaccines industry?

For detailed insights on the mergers and acquisitions in the inactivated vaccines industry, request a sample here.

What are the key dynamics influencing the inactivated vaccines market growth? SWOT analysis of the inactivated vaccines market.

For detailed insights on the key dynamics influencing the inactivated vaccines market growth and SWOT analysis of the inactivated vaccines industry, request a sample here.